Roche Holding AG (RHHBY) Virtual Hematology Investor Conference Transcript

Roche Holding AG (OTCQX:RHHBY) Virtual Hematology Investor Conference Call June 23, 2025 1:00 PM ET Company Participants Bruno Eschli - Head of Investor Relations Charles S. Fuchs - Global Head of Oncology & Hematology Drug Development—Genentech & Roche Daud Chaudry - Corporate Participant Conference Call Participants Colin Peter White - UBS Investment Bank, Research Division David Paul Evans - Kepler Cheuvreux, Research Division Justin Steven Barrie Smith - Sanford C. Bernstein & Co., LLC., Research Divisi ...